Articles by Tim Burroughs
Korean strategics confirm interest in PE-owned Tongyang Magic
SK Networks and Unid have both expressed an interest in Tongyang Magic, a South Korean consumer appliances manufacturer put up for sale by Glenwood Private Equity and NH Private Equity.
Capital Square buys majority stake in India's Indecomm
Singapore-based Capital Square Partners has acquired a majority stake in Indecomm Global Services, an Indian IT services provider.
Deal focus: RocketSpace plots a China trajectory
With support from HNA Group, RocketSpace wants to take its San Francisco-based co-working space and accelerator model into new markets. China is the top priority
CDIB Capital commits $30m to China outdoor sports retailer
CDIB Capital has invested RMB200 million ($30 million) in Tutwo Outdoor, a multi-brand outdoor sporting goods retailer with more than 900 stores across China.
Q&A: CalSTRS' Christopher Ailman
Christopher Ailman, CIO of the California State Teachers’ Retirement System (CalSTRS), explains how his organization’s approach to ESG has evolved and what this means for portfolio managers
Chinese investors to buy Italy's AC Milan for $820m
Haixia Capital, an investment firm controlled by China’s State Development & Investment Corporation, is part of a Chinese consortium that will buy leading Italian football club AC Milan.
Korean brokerage wins license to launch PE arm
South Korean brokerage NH Investment & Securities has been awarded a license to launch a private equity investment unit.
KKR, Warburg Pincus join $550m round for Indonesia's Go-Jek
Indonesian mobile ride-hailing and delivery platform Go-Jek has received $550 million from investors including KKR, Warburg Pincus, Farallon Capital and Capital Group Private Markets.
Vietnam's Mekong backs logistics business, adds two partners
Vietnam-focused Mekong Capital has announced the second investment from its latest fund – cold chain logistics provider ABA Corporation – and also promoted Thanh Giang Vu Pham and Truong Dieu Le to partner. It now has four partners in total.
Primavera, Shanghai Pharma to buy Australia's Vitaco
Primavera Capital and Shanghai Pharmaceuticals have agreed to buy Australia-listed nutrition and healthcare products company Vitaco for approximately A$313 million ($238 million).
Warburg Pincus commits $125m to India logistics start-up
Warburg Pincus has agreed to invest up to $125 million in an India-based supply chain services start-up founded by Anshuman Singh, who previously spent nine years as head of Future Supply Chain Solutions.
Fund T&C: Carrot and stick
Fee discounts and co-investment often dominate GP-LP discourse, but longer-term issues surrounding economics and governance are increasingly important to negotiations over some Asian GPs’ fund terms
Foreign internet players in China: After Uber
Uber's experience in China suggests that foreign internet companies should be careful when picking their battles and wherever possible emphasize the international angle
Local PE funds back $1.1b take-private for China's Trina Solar
China-based solar cell manufacturer Trina Solar has agreed a $1.1 billion take-private deal with a consortium comprising its chairman and CEO as well as several domestic private equity funds.
PE-backed Chinese consortium buys Caesars games business for $4.4b
Yunfeng Capital, Hony Capital and CDH Investments' wealth management platform are part of a consortium that has agreed to buy Caesars Interactive Entertainment’s (CIE) social and mobile games business for $4.4 billion in cash.
Japan Industrial Partners buys Narumiya from SBI
Japan Industrial Partners (JIP) has acquired children’s clothing retailer Narumiya International from SBI Holdings for an undisclosed sum.
Singapore's GIC expects weak returns in coming decade
Singapore sovereign wealth fund GIC Private saw its returns slow over the past year and warned the combination of high asset valuations, low interest rates and uncertain growth is likely to weigh on performance over at least the next decade.
KKR set for $576m windfall from Gland Pharma exit
KKR will exit India-based Gland Pharma as Shanghai Fosun Pharmaceutical acquires a majority stake in the business for up to $1.26 billion. KKR’s share of the proceeds will be $576.3 million, more than twice what it invested in Gland in 2014.
Deal Focus: L Capital taps Korea’s cultural clout
Clio Cosmetics hopes to leverage Korea's entertainment appeal throughout Asia
Malaysia's Ekuinas invests $16.9m in domestic sports retailer
Ekuinas, a private equity firm backed by the Malaysian government, has acquired a 35% interest in Al-Ikhsan Sports, the country’s leading sportswear retailer, for MYR68.6 million ($16.9 million).
Australia's Allegro completes sale of Vulcanite Holdings
Allegro Funds Group has exited Australia-based Vulcanite Holdings to German multinational Continental, five years after acquiring the molded rubber parts specialist through a management buyout.
China's Focus Media commits $150m to four investment funds
Focus Media, the Chinese outdoor advertising business taken private by a PE consortium and re-listed in Shenzhen last year through a reverse merger, is supporting four investment funds seeking to raise a combined RMB2 billion ($300 million).
China venture capital: Contrarian view
While capital is widely available in China's VC scene, investors continue to worry worry that the market is not developing as it should
QIC, Future Fund support AGL's Australia renewables fund
The QIC Global Infrastructure Fund and Future Fund have committed A$800 million ($598 million) to the Powering Australian Renewables Fund (PARF), a vehicle launched by domestic electricity provider AGL Energy to bankroll large-scale renewable energy projects.